カテゴリー： GlobalInfoResearch, 世界, 医療/バイオ

世界の経鼻インフルエンザワクチン市場2022年：三価インフルエンザワクチン、四価インフルエンザワクチン

◆英語タイトル：Global Nasal Flu Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

GlobalInfoResearchが発行した調査報告書（GIR22MY8900）◆商品コード：GIR22MY8900
◆発行会社（リサーチ会社）：GlobalInfoResearch
◆発行日：2022年5月（※2025年版があります。お問い合わせください。）
◆ページ数：73
◆レポート形式：英語 / PDF
◆納品方法：Eメール（注文後2-3日）
◆調査対象地域：グローバル
◆産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

経鼻インフルエンザワクチン市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の経鼻インフルエンザワクチンの市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

経鼻インフルエンザワクチン市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・三価インフルエンザワクチン、四価インフルエンザワクチン

用途別セグメントは次のように区分されます。
・子供、成人

世界の経鼻インフルエンザワクチン市場の主要な市場プレーヤーは以下のとおりです。
・AstraZeneca

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、経鼻インフルエンザワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な経鼻インフルエンザワクチンメーカーの企業概要、2019年～2022年までの経鼻インフルエンザワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な経鼻インフルエンザワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別経鼻インフルエンザワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの経鼻インフルエンザワクチンの種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での経鼻インフルエンザワクチン市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および経鼻インフルエンザワクチンの産業チェーンを掲載しています。
・第13、14、15章では、経鼻インフルエンザワクチンの販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
・メーカー情報（企業概要、製品概要、販売量、価格、売上）：AstraZeneca
・メーカー別市場シェア
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：三価インフルエンザワクチン、四価インフルエンザワクチン
・用途別分析2017年-2028年：子供、成人
・経鼻インフルエンザワクチンの北米市場規模2017年-2028年：アメリカ、カナダ、メキシコ
・経鼻インフルエンザワクチンのヨーロッパ市場規模2017年-2028年：ドイツ、イギリス、フランス、ロシア、イタリア
・経鼻インフルエンザワクチンのアジア市場規模2017年-2028年：中国、日本、韓国、インド、東南アジア、オーストラリア
・経鼻インフルエンザワクチンの南米市場規模2017年-2028年：ブラジル、アルゼンチン
・経鼻インフルエンザワクチンの中東・アフリカ市場規模2017年-2028年：サウジアラビア、トルコ、エジプト、南アフリカ
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Nasal Flu Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Nasal Flu Vaccine market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Child accounting for % of the Nasal Flu Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Trivalent Flu Vaccine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Nasal Flu Vaccine include AstraZeneca, , , , and , etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Nasal Flu Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Trivalent Flu Vaccine
Quadrivalent Flu Vaccine
Market segment by Application can be divided into
Child
Adult
The key market players for global Nasal Flu Vaccine market are listed below:
AstraZeneca
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Nasal Flu Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Nasal Flu Vaccine, with price, sales, revenue and global market share of Nasal Flu Vaccine from 2019 to 2022.
Chapter 3, the Nasal Flu Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Nasal Flu Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Nasal Flu Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Nasal Flu Vaccine.
Chapter 13, 14, and 15, to describe Nasal Flu Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.

❖ レポートの目次 ❖

1 Market Overview
1.1 Nasal Flu Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Nasal Flu Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Trivalent Flu Vaccine
1.2.3 Quadrivalent Flu Vaccine
1.3 Market Analysis by Application
1.3.1 Overview: Global Nasal Flu Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Child
1.3.3 Adult
1.4 Global Nasal Flu Vaccine Market Size & Forecast
1.4.1 Global Nasal Flu Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Nasal Flu Vaccine Sales in Volume (2017-2028)
1.4.3 Global Nasal Flu Vaccine Price (2017-2028)
1.5 Global Nasal Flu Vaccine Production Capacity Analysis
1.5.1 Global Nasal Flu Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Nasal Flu Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Nasal Flu Vaccine Market Drivers
1.6.2 Nasal Flu Vaccine Market Restraints
1.6.3 Nasal Flu Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 AstraZeneca
2.1.1 AstraZeneca Details
2.1.2 AstraZeneca Major Business
2.1.3 AstraZeneca Nasal Flu Vaccine Product and Services
2.1.4 AstraZeneca Nasal Flu Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Nasal Flu Vaccine Breakdown Data by Manufacturer
3.1 Global Nasal Flu Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Nasal Flu Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Nasal Flu Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Nasal Flu Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Nasal Flu Vaccine Manufacturer Market Share in 2021
3.5 Global Nasal Flu Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Nasal Flu Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Nasal Flu Vaccine Market Size by Region
4.1.1 Global Nasal Flu Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Nasal Flu Vaccine Revenue by Region (2017-2028)
4.2 North America Nasal Flu Vaccine Revenue (2017-2028)
4.3 Europe Nasal Flu Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Nasal Flu Vaccine Revenue (2017-2028)
4.5 South America Nasal Flu Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Nasal Flu Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Nasal Flu Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Nasal Flu Vaccine Revenue by Type (2017-2028)
5.3 Global Nasal Flu Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Nasal Flu Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Nasal Flu Vaccine Revenue by Application (2017-2028)
6.3 Global Nasal Flu Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Nasal Flu Vaccine Sales by Type (2017-2028)
7.2 North America Nasal Flu Vaccine Sales by Application (2017-2028)
7.3 North America Nasal Flu Vaccine Market Size by Country
7.3.1 North America Nasal Flu Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Nasal Flu Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Nasal Flu Vaccine Sales by Type (2017-2028)
8.2 Europe Nasal Flu Vaccine Sales by Application (2017-2028)
8.3 Europe Nasal Flu Vaccine Market Size by Country
8.3.1 Europe Nasal Flu Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Nasal Flu Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Nasal Flu Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Nasal Flu Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Nasal Flu Vaccine Market Size by Region
9.3.1 Asia-Pacific Nasal Flu Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Nasal Flu Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Nasal Flu Vaccine Sales by Type (2017-2028)
10.2 South America Nasal Flu Vaccine Sales by Application (2017-2028)
10.3 South America Nasal Flu Vaccine Market Size by Country
10.3.1 South America Nasal Flu Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Nasal Flu Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Nasal Flu Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Nasal Flu Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Nasal Flu Vaccine Market Size by Country
11.3.1 Middle East & Africa Nasal Flu Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Nasal Flu Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Nasal Flu Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Nasal Flu Vaccine
12.3 Nasal Flu Vaccine Production Process
12.4 Nasal Flu Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Nasal Flu Vaccine Typical Distributors
13.3 Nasal Flu Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Nasal Flu Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Nasal Flu Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 4. AstraZeneca Major Business
Table 5. AstraZeneca Nasal Flu Vaccine Product and Services
Table 6. AstraZeneca Nasal Flu Vaccine Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Global Nasal Flu Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 8. Global Nasal Flu Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 9. Market Position of Manufacturers in Nasal Flu Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 10. Global Nasal Flu Vaccine Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Nasal Flu Vaccine Production Site of Key Manufacturer
Table 12. Nasal Flu Vaccine New Entrant and Capacity Expansion Plans
Table 13. Nasal Flu Vaccine Mergers & Acquisitions in the Past Five Years
Table 14. Global Nasal Flu Vaccine Sales by Region (2017-2022) & (K Units)
Table 15. Global Nasal Flu Vaccine Sales by Region (2023-2028) & (K Units)
Table 16. Global Nasal Flu Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 17. Global Nasal Flu Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 18. Global Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 19. Global Nasal Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 20. Global Nasal Flu Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 21. Global Nasal Flu Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 22. Global Nasal Flu Vaccine Price by Type (2017-2022) & (US$/Unit)
Table 23. Global Nasal Flu Vaccine Price by Type (2023-2028) & (US$/Unit)
Table 24. Global Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 25. Global Nasal Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 26. Global Nasal Flu Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 27. Global Nasal Flu Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 28. Global Nasal Flu Vaccine Price by Application (2017-2022) & (US$/Unit)
Table 29. Global Nasal Flu Vaccine Price by Application (2023-2028) & (US$/Unit)
Table 30. North America Nasal Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 31. North America Nasal Flu Vaccine Sales by Country (2023-2028) & (K Units)
Table 32. North America Nasal Flu Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 33. North America Nasal Flu Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 34. North America Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 35. North America Nasal Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 36. North America Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 37. North America Nasal Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 38. Europe Nasal Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 39. Europe Nasal Flu Vaccine Sales by Country (2023-2028) & (K Units)
Table 40. Europe Nasal Flu Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 41. Europe Nasal Flu Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 42. Europe Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 43. Europe Nasal Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 44. Europe Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 45. Europe Nasal Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 46. Asia-Pacific Nasal Flu Vaccine Sales by Region (2017-2022) & (K Units)
Table 47. Asia-Pacific Nasal Flu Vaccine Sales by Region (2023-2028) & (K Units)
Table 48. Asia-Pacific Nasal Flu Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 49. Asia-Pacific Nasal Flu Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 50. Asia-Pacific Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 51. Asia-Pacific Nasal Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 52. Asia-Pacific Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 53. Asia-Pacific Nasal Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 54. South America Nasal Flu Vaccine Sales by Country (2017-2022) & (K Units)
Table 55. South America Nasal Flu Vaccine Sales by Country (2023-2028) & (K Units)
Table 56. South America Nasal Flu Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 57. South America Nasal Flu Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 58. South America Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 59. South America Nasal Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 60. South America Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 61. South America Nasal Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 62. Middle East & Africa Nasal Flu Vaccine Sales by Region (2017-2022) & (K Units)
Table 63. Middle East & Africa Nasal Flu Vaccine Sales by Region (2023-2028) & (K Units)
Table 64. Middle East & Africa Nasal Flu Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 65. Middle East & Africa Nasal Flu Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 66. Middle East & Africa Nasal Flu Vaccine Sales by Type (2017-2022) & (K Units)
Table 67. Middle East & Africa Nasal Flu Vaccine Sales by Type (2023-2028) & (K Units)
Table 68. Middle East & Africa Nasal Flu Vaccine Sales by Application (2017-2022) & (K Units)
Table 69. Middle East & Africa Nasal Flu Vaccine Sales by Application (2023-2028) & (K Units)
Table 70. Nasal Flu Vaccine Raw Material
Table 71. Key Manufacturers of Nasal Flu Vaccine Raw Materials
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Nasal Flu Vaccine Typical Distributors
Table 75. Nasal Flu Vaccine Typical Customers
List of Figures
Figure 1. Nasal Flu Vaccine Picture
Figure 2. Global Nasal Flu Vaccine Revenue Market Share by Type in 2021
Figure 3. Trivalent Flu Vaccine
Figure 4. Quadrivalent Flu Vaccine
Figure 5. Global Nasal Flu Vaccine Revenue Market Share by Application in 2021
Figure 6. Child
Figure 7. Adult
Figure 8. Global Nasal Flu Vaccine Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 9. Global Nasal Flu Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 10. Global Nasal Flu Vaccine Sales (2017-2028) & (K Units)
Figure 11. Global Nasal Flu Vaccine Price (2017-2028) & (US$/Unit)
Figure 12. Global Nasal Flu Vaccine Production Capacity (2017-2028) & (K Units)
Figure 13. Global Nasal Flu Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 14. Nasal Flu Vaccine Market Drivers
Figure 15. Nasal Flu Vaccine Market Restraints
Figure 16. Nasal Flu Vaccine Market Trends
Figure 17. Global Nasal Flu Vaccine Sales Market Share by Manufacturer in 2021
Figure 18. Global Nasal Flu Vaccine Revenue Market Share by Manufacturer in 2021
Figure 19. Nasal Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 20. Top 3 Nasal Flu Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 21. Top 6 Nasal Flu Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Global Nasal Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 23. Global Nasal Flu Vaccine Revenue Market Share by Region (2017-2028)
Figure 24. North America Nasal Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 25. Europe Nasal Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Asia-Pacific Nasal Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. South America Nasal Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. Middle East & Africa Nasal Flu Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Global Nasal Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 30. Global Nasal Flu Vaccine Revenue Market Share by Type (2017-2028)
Figure 31. Global Nasal Flu Vaccine Price by Type (2017-2028) & (US$/Unit)
Figure 32. Global Nasal Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 33. Global Nasal Flu Vaccine Revenue Market Share by Application (2017-2028)
Figure 34. Global Nasal Flu Vaccine Price by Application (2017-2028) & (US$/Unit)
Figure 35. North America Nasal Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 36. North America Nasal Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 37. North America Nasal Flu Vaccine Sales Market Share by Country (2017-2028)
Figure 38. North America Nasal Flu Vaccine Revenue Market Share by Country (2017-2028)
Figure 39. United States Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 40. Canada Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Mexico Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Europe Nasal Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 43. Europe Nasal Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 44. Europe Nasal Flu Vaccine Sales Market Share by Country (2017-2028)
Figure 45. Europe Nasal Flu Vaccine Revenue Market Share by Country (2017-2028)
Figure 46. Germany Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 47. France Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. United Kingdom Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. Russia Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Italy Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Asia-Pacific Nasal Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 52. Asia-Pacific Nasal Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 53. Asia-Pacific Nasal Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Nasal Flu Vaccine Revenue Market Share by Region (2017-2028)
Figure 55. China Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Japan Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Korea Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. India Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Southeast Asia Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Australia Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. South America Nasal Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 62. South America Nasal Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 63. South America Nasal Flu Vaccine Sales Market Share by Country (2017-2028)
Figure 64. South America Nasal Flu Vaccine Revenue Market Share by Country (2017-2028)
Figure 65. Brazil Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Argentina Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Middle East & Africa Nasal Flu Vaccine Sales Market Share by Type (2017-2028)
Figure 68. Middle East & Africa Nasal Flu Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Middle East & Africa Nasal Flu Vaccine Sales Market Share by Region (2017-2028)
Figure 70. Middle East & Africa Nasal Flu Vaccine Revenue Market Share by Region (2017-2028)
Figure 71. Turkey Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. Egypt Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Saudi Arabia Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. South Africa Nasal Flu Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Manufacturing Cost Structure Analysis of Nasal Flu Vaccine in 2021
Figure 76. Manufacturing Process Analysis of Nasal Flu Vaccine
Figure 77. Nasal Flu Vaccine Industrial Chain
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
Figure 79. Methodology
Figure 80. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ 世界の経鼻インフルエンザワクチン市場2022年：三価インフルエンザワクチン、四価インフルエンザワクチン(Global Nasal Flu Vaccine Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • 世界のヒト注射インフルエンザワクチン市場インサイト及び予測（三価インフルエンザワクチン、四価インフルエンザワクチン）
  • 世界のインフルエンザワクチン注射市場インサイト及び予測（三価インフルエンザワクチン、四価インフルエンザワクチン）
  • 世界のインフルエンザ予防接種市場インサイト及び予測（三価インフルエンザワクチン、四価インフルエンザワクチン）
  • 世界のヒトロタウイルスワクチン市場2022年：Rotarix、 RotaTeq、 Rotavac、 Rotavin-M1、 Lanzhou lamb、その他
  • 世界の犬用インフルエンザワクチン市場2022年：液体、粉体